Myanmar

Myanmar

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
8.7 2013 Survey/reported Zaw S et al, 2013
4.18 (0.28 - 41.28) 2015 Modelled WHO
8.3 (4.60 - 9.40) 2016 Modelled Razavi-Shearer et al, 2018
3.4 (3.26 - 3.54) 2013 Modelled Schweitzer et al, 2015
2.39 (1.99 - 2.71) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.61 (2.22 - 2.93) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.65 (2.27 - 3.01) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.68 (2.29 - 3.02) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.71 (2.31 - 3.09) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.76 (2.36 - 3.14) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.83 (2.42 - 3.23) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.91 (2.49 - 3.33) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.53 - 3.44) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.01 (2.53 - 3.49) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.03 (2.55 - 3.51) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.59 - 3.55) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.14 (2.62 - 3.60) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3.19 (2.65 - 3.67) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.21 (2.66 - 3.71) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.23 (2.69 - 3.72) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.26 (2.73 - 3.77) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.3 (2.77 - 3.80) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.34 (2.79 - 3.84) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.37 (2.81 - 3.88) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.39 (2.85 - 3.90) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.43 (2.90 - 3.95) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.47 (2.95 - 4) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.5 (2.97 - 4.04) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.51 (2.97 - 4.07) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.5 (2.96 - 4.05) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.48 (2.92 - 4.02) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.45 (2.88 - 3.98) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.4 (2.83 - 3.93) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.35 (2.76 - 3.87) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (2.11 - 2.86) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.03 (0.13 - 25.84) 2015 Modelled WHO
0.61 (0.46 - 0.82) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.7 (0.53 - 0.93) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.57 - 1) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.58 - 1.04) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.63 - 1.09) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.65 - 1.13) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.65 - 1.11) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.64 - 1.09) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.62 - 1.08) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.59 - 1.08) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.59 - 1.08) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.60 - 1.08) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.62 - 1.11) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.65 - 1.16) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.69 - 1.23) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.74 - 1.33) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.2 (0.89 - 1.55) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.53 (1.15 - 1.97) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.44 - 2.49) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.25 (1.69 - 2.94) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.81 - 3.17) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (1.85 - 3.22) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (1.86 - 3.27) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (1.87 - 3.30) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.90 - 3.33) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.88 - 3.35) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (1.89 - 3.32) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.53 (1.88 - 3.27) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (1.84 - 3.21) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.45 (1.81 - 3.15) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.39 (1.74 - 3.07) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (0.91 - 1.32) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
4,376,000 (2,427,000 - 4,950,000) 2016 Modelled Razavi-Shearer et al, 2018
1,307,320 (1,086,240 - 1,479,900) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1,348,190 (1,117,630 - 1,520,160) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,377,140 (1,169,760 - 1,547,020) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,387,200 (1,189,860 - 1,575,290) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,388,500 (1,189,260 - 1,565,090) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,395,150 (1,191,070 - 1,592,580) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,408,800 (1,201,480 - 1,609,250) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,434,420 (1,226,700 - 1,639,470) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,462,240 (1,248,560 - 1,678,720) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,482,600 (1,259,120 - 1,711,450) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,486,060 (1,251,970 - 1,726,790) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,486,350 (1,251,840 - 1,723,850) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,500,720 (1,258,500 - 1,726,300) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,518,820 (1,265,900 - 1,744,370) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,530,340 (1,272,260 - 1,760,050) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,529,540 (1,268,020 - 1,764,630) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,525,300 (1,267,940 - 1,761,910) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,528,920 (1,276,260 - 1,767,620) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,535,280 (1,286,740 - 1,764,150) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,539,370 (1,285,720 - 1,770,680) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,536,060 (1,279,240 - 1,772,400) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,531,490 (1,285,520 - 1,757,660) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,532,340 (1,291,260 - 1,765,890) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,533,220 (1,300,210 - 1,769,800) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,529,140 (1,298,930 - 1,767,730) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,515,320 (1,282,660 - 1,756,580) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,492,510 (1,262,010 - 1,729,580) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,464,860 (1,230,850 - 1,690,500) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,432,190 (1,197,340 - 1,653,140) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,394,480 (1,161,680 - 1,611,380) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,351,670 (1,117,590 - 1,566,600) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
12.2 (8.57 - 17.20) 2019 Modelled IHME, GBD 2019 (accessed 2020)
15.05 (10.65 - 20.71) 1992 Modelled IHME, GBD 2019 (accessed 2022)
14.89 (10.62 - 20.39) 1990 Modelled IHME, GBD 2019 (accessed 2022)
15 (10.74 - 20.72) 1991 Modelled IHME, GBD 2019 (accessed 2022)
15.09 (10.79 - 20.43) 1993 Modelled IHME, GBD 2019 (accessed 2022)
15.12 (10.81 - 20.75) 1994 Modelled IHME, GBD 2019 (accessed 2022)
15.14 (10.88 - 20.61) 1995 Modelled IHME, GBD 2019 (accessed 2022)
15.18 (10.97 - 20.33) 1998 Modelled IHME, GBD 2019 (accessed 2022)
15.15 (10.88 - 20.58) 1996 Modelled IHME, GBD 2019 (accessed 2022)
15.15 (10.97 - 20.35) 1997 Modelled IHME, GBD 2019 (accessed 2022)
15.18 (10.96 - 20.15) 1999 Modelled IHME, GBD 2019 (accessed 2022)
15.43 (11.32 - 20.21) 2000 Modelled IHME, GBD 2019 (accessed 2022)
15.7 (11.57 - 20.38) 2001 Modelled IHME, GBD 2019 (accessed 2022)
15.84 (11.64 - 20.66) 2002 Modelled IHME, GBD 2019 (accessed 2022)
15.86 (11.65 - 20.51) 2003 Modelled IHME, GBD 2019 (accessed 2022)
16.02 (11.94 - 20.68) 2004 Modelled IHME, GBD 2019 (accessed 2022)
16.05 (12.08 - 20.55) 2006 Modelled IHME, GBD 2019 (accessed 2022)
16 (11.92 - 20.61) 2005 Modelled IHME, GBD 2019 (accessed 2022)
15.95 (12.27 - 20.23) 2007 Modelled IHME, GBD 2019 (accessed 2022)
15.77 (12.28 - 20.04) 2008 Modelled IHME, GBD 2019 (accessed 2022)
15.74 (12.28 - 20.06) 2009 Modelled IHME, GBD 2019 (accessed 2022)
15.6 (12.08 - 19.93) 2010 Modelled IHME, GBD 2019 (accessed 2022)
14.65 (11.14 - 18.82) 2012 Modelled IHME, GBD 2019 (accessed 2022)
15.4 (11.84 - 19.75) 2011 Modelled IHME, GBD 2019 (accessed 2022)
13.11 (9.64 - 17.17) 2014 Modelled IHME, GBD 2019 (accessed 2022)
13.91 (10.47 - 17.91) 2013 Modelled IHME, GBD 2019 (accessed 2022)
12.46 (9 - 16.73) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11.97 (8.64 - 16.34) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12.03 (8.62 - 16.54) 2017 Modelled IHME, GBD 2019 (accessed 2022)
12.15 (8.57 - 17.15) 2019 Modelled IHME, GBD 2019 (accessed 2022)
12.25 (8.72 - 17.17) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
14,284 2016 Modelled WHO
6,367 (4,504 - 8,762) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6,119 (4,365 - 8,381) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6,256 (4,482 - 8,643) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6,473 (4,629 - 8,763) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6,567 (4,697 - 9,016) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6,659 (4,784 - 9,065) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6,739 (4,840 - 9,157) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6,973 (5,037 - 9,256) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6,901 (4,988 - 9,245) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6,817 (4,933 - 9,154) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7,159 (5,253 - 9,379) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7,494 (5,509 - 9,775) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7,357 (5,424 - 9,551) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7,572 (5,563 - 9,797) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7,721 (5,755 - 9,965) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7,873 (5,928 - 10,084) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7,892 (6,073 - 10,012) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7,781 (5,794 - 10,024) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7,865 (6,122 - 9,992) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7,905 (6,166 - 10,074) 2009 Modelled IHME, GBD 2019 (accessed 2022)
7,872 (6,049 - 10,093) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7,906 (6,119 - 10,096) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7,550 (5,741 - 9,700) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7,232 (5,443 - 9,314) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6,878 (5,054 - 9,005) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6,591 (4,760 - 8,848) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6,386 (4,610 - 8,717) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6,473 (4,639 - 8,894) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6,643 (4,728 - 9,313) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6,644 (4,685 - 9,380) 2019 Modelled IHME, GBD 2019 (accessed 2022)
6,644 (4,685 - 9,380) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
5 (3 - 7) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2009 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 14) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2011 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2012 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2015 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2016 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 18) 2017 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 21) 2018 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 21) 2019 Modelled IHME, GBD 2019 (accessed 2022)
33 (25 - 43) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
17 2019 Survey/reported WHO/UNICEF
7 2018 Survey/reported WHO/UNICEF
1 2017 Survey/reported WHO/UNICEF
21 2020 Survey/reported WHO/UNICEF
6 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
90 2019 Survey/reported WHO/UNICEF
84 2020 Survey/reported WHO/UNICEF
37 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
80 (59 - 120) 2015 Survey/reported HIV And AIDS Data Hub for Asia-Pacific, 2014; Myanmar National AIDS Programme, 2015.
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2016
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.88 (1.53 - 2.30) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.54 - 2.31) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.53 - 2.32) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.55 - 2.31) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.54 - 2.32) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.54 - 2.32) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.9 (1.54 - 2.33) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.9 (1.54 - 2.36) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.53 - 2.35) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.53 - 2.37) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.55 - 2.38) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.93 (1.56 - 2.39) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.57 - 2.40) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.95 (1.57 - 2.42) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.96 (1.59 - 2.44) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.98 (1.60 - 2.45) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2 (1.62 - 2.47) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.02 (1.63 - 2.49) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.04 (1.66 - 2.51) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.66 - 2.52) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.06 (1.67 - 2.53) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.68 - 2.55) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.68 - 2.57) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.09 (1.68 - 2.57) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (1.68 - 2.59) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (1.69 - 2.58) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (1.69 - 2.58) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (1.68 - 2.60) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (1.68 - 2.59) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (1.68 - 2.59) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.82 (1.48 - 2.22) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.5 (0.34 - 0.56) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.95 (0.34 - 2.03) 2010 Survey/reported Myo-Khin et al, 2010
1.7 (1 - 2.70) 2014 Survey/reported Gower et al, 2014
2 2019 Modelled Jin et al. 2017
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
3.4 (1.30 - 7.20) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
29.5 (26.90 - 32.20) 2010 Modelled Degenhardt L et al, 2017
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
3.4 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
852,966 (677,522 - 1,050,080) 1990 Modelled IHME, GBD 2019 (accessed 2022)
864,888 (689,658 - 1,061,080) 1991 Modelled IHME, GBD 2019 (accessed 2022)
876,081 (699,607 - 1,081,870) 1992 Modelled IHME, GBD 2019 (accessed 2022)
886,555 (710,609 - 1,090,060) 1993 Modelled IHME, GBD 2019 (accessed 2022)
896,289 (720,473 - 1,102,450) 1994 Modelled IHME, GBD 2019 (accessed 2022)
905,239 (726,593 - 1,118,440) 1995 Modelled IHME, GBD 2019 (accessed 2022)
913,409 (736,915 - 1,125,270) 1996 Modelled IHME, GBD 2019 (accessed 2022)
920,732 (743,371 - 1,136,930) 1997 Modelled IHME, GBD 2019 (accessed 2022)
927,147 (749,099 - 1,142,070) 1998 Modelled IHME, GBD 2019 (accessed 2022)
932,622 (754,587 - 1,144,260) 1999 Modelled IHME, GBD 2019 (accessed 2022)
937,093 (759,291 - 1,149,070) 2000 Modelled IHME, GBD 2019 (accessed 2022)
939,147 (762,193 - 1,152,680) 2001 Modelled IHME, GBD 2019 (accessed 2022)
938,398 (757,875 - 1,155,350) 2002 Modelled IHME, GBD 2019 (accessed 2022)
936,387 (758,016 - 1,158,460) 2003 Modelled IHME, GBD 2019 (accessed 2022)
934,695 (758,143 - 1,158,690) 2004 Modelled IHME, GBD 2019 (accessed 2022)
934,972 (756,042 - 1,159,720) 2005 Modelled IHME, GBD 2019 (accessed 2022)
937,141 (755,491 - 1,161,700) 2006 Modelled IHME, GBD 2019 (accessed 2022)
939,869 (759,641 - 1,162,030) 2007 Modelled IHME, GBD 2019 (accessed 2022)
941,642 (760,044 - 1,167,770) 2008 Modelled IHME, GBD 2019 (accessed 2022)
943,663 (761,055 - 1,171,750) 2009 Modelled IHME, GBD 2019 (accessed 2022)
947,113 (755,837 - 1,172,540) 2010 Modelled IHME, GBD 2019 (accessed 2022)
950,954 (764,748 - 1,175,070) 2011 Modelled IHME, GBD 2019 (accessed 2022)
955,629 (772,733 - 1,186,110) 2012 Modelled IHME, GBD 2019 (accessed 2022)
961,125 (779,104 - 1,181,230) 2013 Modelled IHME, GBD 2019 (accessed 2022)
967,405 (784,111 - 1,186,150) 2014 Modelled IHME, GBD 2019 (accessed 2022)
974,349 (793,054 - 1,193,520) 2015 Modelled IHME, GBD 2019 (accessed 2022)
980,985 (804,223 - 1,200,380) 2016 Modelled IHME, GBD 2019 (accessed 2022)
987,704 (802,826 - 1,214,740) 2017 Modelled IHME, GBD 2019 (accessed 2022)
993,864 (813,844 - 1,216,250) 2018 Modelled IHME, GBD 2019 (accessed 2022)
993,498 (808,255 - 1,214,050) 2019 Modelled IHME, GBD 2019 (accessed 2020)
998,587 (812,734 - 1,219,920) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
74,500 (50,900 - 84,200) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
12.5 (8.81 - 17.10) 2019 Modelled IHME, GBD 2019 (accessed 2020)
10.05 (6.83 - 14.11) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9.97 (6.87 - 13.98) 1990 Modelled IHME, GBD 2019 (accessed 2022)
10.02 (6.83 - 14.03) 1991 Modelled IHME, GBD 2019 (accessed 2022)
10.08 (6.82 - 14.20) 1994 Modelled IHME, GBD 2019 (accessed 2022)
10.07 (6.77 - 14.19) 1993 Modelled IHME, GBD 2019 (accessed 2022)
10.09 (6.87 - 14.14) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10.08 (6.89 - 14.09) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10.08 (7.15 - 14.12) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10.08 (6.97 - 13.99) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10.08 (7.05 - 14.05) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10.26 (7.23 - 14.21) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10.48 (7.44 - 14.39) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10.62 (7.59 - 14.56) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10.69 (7.62 - 14.76) 2003 Modelled IHME, GBD 2019 (accessed 2022)
10.85 (7.75 - 15) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10.87 (7.85 - 15.11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
10.85 (7.79 - 15.05) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10.76 (7.78 - 14.90) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10.6 (7.67 - 14.66) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10.55 (7.65 - 14.50) 2009 Modelled IHME, GBD 2019 (accessed 2022)
10.46 (7.58 - 14.29) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10.76 (7.82 - 14.66) 2012 Modelled IHME, GBD 2019 (accessed 2022)
11.16 (8.03 - 15.05) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10.6 (7.61 - 14.41) 2011 Modelled IHME, GBD 2019 (accessed 2022)
11.54 (8.31 - 15.45) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11.78 (8.47 - 16.05) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11.94 (8.54 - 16.25) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12.38 (8.81 - 16.93) 2017 Modelled IHME, GBD 2019 (accessed 2022)
12.49 (8.81 - 17.15) 2019 Modelled IHME, GBD 2019 (accessed 2022)
12.63 (8.94 - 17.33) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
3,792 2016 Modelled WHO
6,829 (4,819 - 9,376) 2019 Modelled IHME, GBD 2019 (accessed 2022)
6,829 (4,819 - 9,376) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6,849 (4,849 - 9,398) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6,660 (4,741 - 9,106) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6,370 (4,558 - 8,669) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6,233 (4,481 - 8,488) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6,054 (4,359 - 8,105) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5,802 (4,177 - 7,825) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5,548 (4,029 - 7,556) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5,418 (3,891 - 7,365) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5,300 (3,840 - 7,241) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5,297 (3,841 - 7,285) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5,287 (3,825 - 7,307) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5,326 (3,850 - 7,375) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5,332 (3,852 - 7,415) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5,278 (3,787 - 7,319) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5,227 (3,735 - 7,231) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5,107 (3,638 - 7,050) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5,026 (3,591 - 6,890) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4,910 (3,487 - 6,742) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4,761 (3,356 - 6,592) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4,632 (3,286 - 6,486) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4,585 (3,207 - 6,389) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4,532 (3,134 - 6,295) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4,485 (3,064 - 6,269) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4,435 (3,022 - 6,219) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4,377 (2,964 - 6,167) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4,319 (2,903 - 6,086) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4,252 (2,890 - 5,972) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4,182 (2,848 - 5,853) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4,096 (2,823 - 5,747) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
4 (3 - 6) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (2 - 6) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 7) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7 (4 - 9) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2005 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 14) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2017 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 19) 2019 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 19) 2018 Modelled IHME, GBD 2019 (accessed 2022)
30 (22 - 39) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
80 (59 - 120) 2015 Survey/reported HIV And AIDS Data Hub for Asia-Pacific, 2014; Myanmar National AIDS Programme, 2015.
Technical notes

Number of 28-pill count bottles exported from Indian manufacturers (SOF-based regimens)

National
Download
Value Year Type Source
25,167 2016 Survey/reported CHAI HCV Market Report
20,329 2017 Survey/reported CHAI HCV Market Report
52,497 2018 Survey/reported CHAI HCV Market Report
99,305 2019 Survey/reported CHAI HCV Market Report
Showing out of
Show more
Technical notes

Price of HCV cure (Lowest average FOB price for 3 months of pangenotypic regimens)

National
Download
Value (US $) Year Type Source
285 2016 Survey/reported CHAI HCV Market Report
216 2017 Survey/reported CHAI HCV Market Report
108 2018 Survey/reported CHAI HCV Market Report
81 2019 Survey/reported CHAI HCV Market Report
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women
HepB birth dose policy
Yes
Year of birth dose introduction
2016
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
No
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Hepatitis related deaths (national)

Modelled

HBV
6,644
2019
(4,685 - 9,380)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
6,829
2019
(4,819 - 9,376)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
6 (%)
2021
WHO/UNICEF
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources